A randomized, placebo-controlled, double-blind, multicenter, phase III study investigating the efficacy and safety of trimodulin (BT588) as addon therapy to standard care in adult subjects with severe community-acquired pneumonia (sCAP)
IP: MARIA DEL CARMEN DE LA FUENTE MARTOS
Activos en 2023